NCT06437054View on ClinicalTrials.gov

Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

February 15, 2026

Study Completion Date

September 30, 2028

Conditions
Hearing Loss, SensorineuralHearing Loss, SuddenIntratympanic Injection
Interventions
DRUG

Dexamethasone

Dexamethasone 5mg/ml

DRUG

Hyaluronic acid

Hyaluronic Acid 20mg/2ml

OTHER

Indocyanine green(ICG)

ICG 25mg

All Listed Sponsors
lead

Seoul National University Hospital

OTHER